Bain Capital Set to Acquire Mitsubishi Tanabe Pharma for $3.3 Billion

In a significant move within the pharmaceutical sector, Bain Capital has announced its intent to acquire Mitsubishi Tanabe Pharma Corporation in a deal valued at $3.3 billion. This acquisition marks a pivotal moment for Bain, as it expands its footprint in the biopharmaceutical industry, acquiring one of Japan's notable pharmaceutical firms.

Continue reading